Study assessing the longitudinal pathologic course of older individuals who show PET-measured MTL tau pathology in the absence of Aβ pathology
Latest Information Update: 13 Sep 2022
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
Most Recent Events
- 13 Sep 2022 New trial record
- 04 Aug 2022 Results presented at the Alzheimer's Association International Conference 2022